Longeveron, Inc. (LGVN)

NASDAQ: LGVN · IEX Real-Time Price · USD
4.27
+0.24 (5.96%)
At close: Sep 28, 2022 4:00 PM
4.13
-0.14 (-3.28%)
After-hours: Sep 28, 2022 7:59 PM EDT
5.96%
Market Cap 89.61M
Revenue (ttm) 1.28M
Net Income (ttm) -18.06M
Shares Out 20.99M
EPS (ttm) -0.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,141,050
Open 4.78
Previous Close 4.03
Day's Range 3.93 - 4.81
52-Week Range 2.84 - 45.00
Beta n/a
Analysts Buy
Price Target 18.38 (+330.4%)
Earnings Date Aug 12, 2022

About LGVN

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left he... [Read more...]

Industry Biotechnology
IPO Date Feb 12, 2021
Employees 18
Stock Exchange NASDAQ
Ticker Symbol LGVN
Full Company Profile

Financial Performance

In 2021, Longeveron's revenue was $1.31 million, a decrease of -76.80% compared to the previous year's $5.63 million. Losses were -$17.05 million, 358.1% more than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for LGVN stock is "Buy." The 12-month stock price forecast is 18.38, which is an increase of 330.44% from the latest price.

Price Target
$18.38
(330.44% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Longeveron Names Jerome Bailey Vice President of Business Operations

Executive brings more than 30 years of global biopharmaceutical operations and program management experience Executive brings more than 30 years of global biopharmaceutical operations and program manage...

1 week ago - GlobeNewsWire

Longeveron to Present at H.C. Wainwright 24th Annual Global Investment Conference

MIAMI, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and l...

3 weeks ago - GlobeNewsWire

Why Is Longeveron (LGVN) Stock on the Move Today?

Source: shutterstock.com/Anastasia Zagoruyko Longeveron (NASDAQ: LGVN ) stock is on the move Wednesday after the FDA granted its fast-track designation for Lomecel-B. Lomecel-B is a allogeneic, bone mar...

4 weeks ago - InvestorPlace

U.S. Food and Drug Administration (FDA) Grants Fast Track Designation for Longeveron's Lomecel-B™ Product for Treatme...

New designation may expedite FDA review and potential approval to address this life-threatening heart condition affecting approximately 1,000 babies per year New designation may expedite FDA review and ...

4 weeks ago - GlobeNewsWire

Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel...

Issued claims will protect use of a biomarker to assess response to Lomecel-B™ in patients with blood vessel dysfunction Issued claims will protect use of a biomarker to assess response to Lomecel-B™ in...

1 month ago - GlobeNewsWire

Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2022 Financial Results

—Longeveron's Phase 2a trial of Lomecel-B for patients with mild Alzheimer's Disease proceeding on schedule, currently at 50% enrollment

1 month ago - GlobeNewsWire

Longeveron to Announce Second Quarter 2022 Financial Results on August 12, 2022

Live conference call on Friday, August 12 at 8:30 a.m. EST Live conference call on Friday, August 12 at 8:30 a.m. EST

1 month ago - GlobeNewsWire

Longeveron Announces Abstract Accepted for Presentation at the Alzheimer's Association International Conference (AAIC)

MIAMI, July 07, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, ...

2 months ago - GlobeNewsWire

How to Buy Stocks in a Recession

The same strategies for buying stocks during a bull market don't apply during a recession. Learn what you need to do going forward.

Other symbols: CRSPENSVMMLPSMLPVOLT
4 months ago - InvestorPlace

Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results

Conference call scheduled for 8:30 a.m. ET today Conference call scheduled for 8:30 a.m. ET today

4 months ago - GlobeNewsWire

Longeveron Announces CEO Transition

-Geoff Green stepping down as CEO, effective June 1, 2022

4 months ago - GlobeNewsWire

Longeveron to Announce First Quarter 2022 Financial Results on May 13, 2022

Live conference call at 8:30 a.m. EST Live conference call at 8:30 a.m. EST

4 months ago - GlobeNewsWire

Follow the Insiders and Buy the Dip in These 3 Stocks

These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments.

Other symbols: ENTXTCON
4 months ago - InvestorPlace

Longeveron to Present at Longevity Leaders World Congress; Latinos and Alzheimer's Symposium; International Frailty a...

April events to highlight Longeveron's commitment to developing cell therapeutics for chronic aging related diseases. April events to highlight Longeveron's commitment to developing cell therapeutics fo...

5 months ago - GlobeNewsWire

Longeveron Enters into Cooperative Research and Development Agreement with the US Department of Veterans Affairs for ...

This third collaboration with the Miami VA shows Longeveron's commitment to improving the health of our nation's Veterans This third collaboration with the Miami VA shows Longeveron's commitment to impr...

5 months ago - GlobeNewsWire

5 Short Squeeze Candidates To Watch: Aterian Tops The List, System1 Group And Longeveron Join Leaderboard

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

Other symbols: ATERSSTGFAINEGG
5 months ago - Benzinga

Recession Fears are Creating a Golden Opportunity for Biotech Stocks

Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now. The post Recession Fears are Creating a Golden Opportunity for Biotech Sto...

5 months ago - InvestorPlace

Longeveron Expands Executive Leadership Team; Appoints K. Chris Min, M.D.

Dr. Min will lead global clinical development and regulatory strategy Dr. Min will lead global clinical development and regulatory strategy

5 months ago - GlobeNewsWire

Alzheimer's News: Why Is Drugmaker Longeveron (LGVN) Soaring Today?

Longeveron (LGVN) stock is taking off on Thursday after the drugmaker published news related to an Alzheimer's treatment. The post Alzheimer's News: Why Is Drugmaker Longeveron (LGVN) Soaring Today?

5 months ago - InvestorPlace

Why Longeveron Shares Are Surging Today

Longeveron Inc (NASDAQ: LGVN) shares are trading higher Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with mild Alzheimer's disease i...

5 months ago - Benzinga

Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer's Disease in Alzheimer's...

Results Support Further Exploration of Therapeutic Potential of Lomecel-B to Slow Cognitive Decline, Improve Quality of Life for Alzheimer's Patients

5 months ago - GlobeNewsWire

Longeveron Presents at Second Euro-Geroscience Conference

Longeveron management presents live at the Second Euro-Geroscience Conference and at a pre-meeting task force Longeveron management presents live at the Second Euro-Geroscience Conference and at a pre-m...

6 months ago - GlobeNewsWire

5 Cheap Energy Stocks Riding Oil Higher

Energy is understandably at the top of every investor's mind right now, but finding the best energy stocks requires careful consideration. The post 5 Cheap Energy Stocks Riding Oil Higher appeared first...

Other symbols: ARBKENSVNVAX
6 months ago - InvestorPlace

Longeveron to Present at Oppenheimer 32nd Annual Healthcare Conference

MIAMI, March 15, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and ...

6 months ago - GlobeNewsWire

Longeveron Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress

Currently Enrolling Clinical Trials with Lomecel-B in Three Disease Indications: Hypoplastic Left Heart Syndrome (Phase 2a), Alzheimer's Disease (Phase 2a), and Covid-related Acute Respiratory Distress ...

6 months ago - GlobeNewsWire